Bradykinin B2-receptor-mediated stimulation of exocytotic noradrenaline release from cardiac sympathetic neurons

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 9, 1997, Pages 2561-2569

  Kurz, Thomas ^a   Tölg, Ralph ^a   Richardt, Gert ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Bradykinin; Exocytosis; Noradrenaline; Phospholipase A2; Sympathetic neuron

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR; BISINDOLYLMALEIMIDE; BRADYKININ; BRADYKININ B2 RECEPTOR; DESIPRAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GENISTEIN; ICATIBANT; NITRIC OXIDE; NORADRENALIN; PHOSPHOLIPASE A2; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; BRADYKININ RECEPTOR;

ADRENERGIC TRANSMISSION; ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRIC FIELD; ELECTROCHEMICAL DETECTION; ENZYME INHIBITION; EXOCYTOSIS; HEART; HEART MUSCLE ISCHEMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; STIMULATION; SYMPATHETIC NERVE CELL; ADRENERGIC SYSTEM; ANIMAL; DRUG ANTAGONISM; DRUG POTENTIATION; ELECTROSTIMULATION; HEART MUSCLE; IN VITRO STUDY; METABOLISM; METHODOLOGY; NERVE CELL; PERFUSION; WISTAR RAT;

ANIMALIA;

ANIMALS; BRADYKININ; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTRIC STIMULATION; MALE; MYOCARDIUM; NEURONS; NOREPINEPHRINE; PERFUSION; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM;

EID: 0031215257     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1997.0492     Document Type: Article

References (36)

1. BAUMGARTEN CR, LINZ W, KUNKEL G, SCHÖLKENS BA, WIEMER G, 1993. Rampirilat increases bradykinin outflow from isolated hearts of rat. Br J Pharmacol 108: 293-295.
2. BURCH RM, KYLE DJ, 1992. RECENT DEVELOPMENTS IN THE UNDERSTANDING OF BRADYKININ RECEPTORS. Life Sci 50: 829-838.
3. CHULAK C, COUTURE R, FOUCART S, 1995. Modulatory effect of bradykinin on the release of noradrenaline from rat isolated atria. Br J Pharmacol 115: 330-334.
4. CULLEN MJ, COCKCROFT JR, WEBB DJ, 1990. Bradykinin has no acute effect on the response of forearm blood flow to sympathetic stimulation in man. Clin Sci 78: 399-401.
5. 2+ cycling in cardiac myocytes by arachidonic acid. Circ Res 72: 376-386.
6. DOMINIAK P, SIMON M, BLÖCHL A, BRENNER P, 1992. Changes in peripheral sympathetic outflow of pithed spontaneously hypertensive rats after bradykinin and DesArg-bradykinin infusions: Influence of converting-enzyme inhibition. J Cardiovasc Pharmacol 91:S35-S38.
7. FARHY RD, CARRETERO OA, HO K-L, SCICLI, AG, 1993. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res 72: 1202-1210.
8. FARMER SG, BURCH RM, 1992. Biochemical and molecular pharmacology of kinin receptors. Annu Rev Pharmacol Toxicol 32: 511-536.
9. 2. FASEB J 8: 916-924.
10. 2U receptors does not correlate well with protein kinase C activation. Naunyn-Schmiedeberg's Arch Pharmacol 351: 194-201.
11. HARVEY SC, 1978. Effects of nerve stimulation and drugs on the release of histamine and noradrenaline from the isolated heart. Jap Heart J 20: 183-193.
12. HESS JF, BORKOWSKI JA, YOUNG GS, STRADER CD, RANSOM RW, 1992. Cloning and pharmacological characterization of human bradykinin (BK-2) receptor. Biochem Biophys Res Commun 45: 1-8.
13. HSUEH W, ISAKSON P, NEEDLEMAN P, 1977. Hormone selective lipase activation in the isolated rabbit heart. Prostaglandins 13: 1073-1091.
14. 3H)-noradrenaline. Br J Pharmacol 94: 713-720.
15. KNEPEL W, SCHOFL C, GOTZ D, 1987. Arachidonic acid elevates cytosolic free calcium concentration in rat anterior pituitary cells. Naunyn-Schmiedeberg's Arch Pharmacol 338: 303-309.
16. KURZ T, RICHARDT G, HAGL S, SEYFARTH M, SCHÖMIG A, 1995. Two different mechanisms of noradrenaline release during normoxia and simulated ischemia in human cardiac tissue. J Moll Cell Cardiol 27: 1161-1172.
17. 2+ entry by tyrosine kinase inhibitors. J Biol Chem 268: 9945-9948.
18. LINZ W, WIEMER G, SCHÖLKENS BA, 1993. Contribution of bradykinin to the cardiovascular effects of ramipril. J Cardiovasc Pharmacol 22 (Suppl. 9): S1-S8.
19. LLONA I, GALLEGUILLOS X, BELMAR J, HUIDOBRO-TORO JP, 1991. Bradykinin modulates the release of nor-adrenaline from vas deferens nerve terminals. Life Sci 48: 2585-2592.
20. MINSHALL RD, YELAMANCHI VP, DJOKOVIC A, MILETICH DJ, ERDÖS EG, RABITO SF, VOGEL SM, 1994. Importance of sympathetic innervation in the positive inotropic effect of bradykinin and ramiprilat. Circ Res 74: 441-447.
21. NODA K, SASAGURI M, IDEISHI M, IKEDA M, ARAKAWA K, 1993. Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Cardiovasc Res 27: 334-340.
22. 2 receptor antagonists upon bradykinin-stimulated phospholipase C and D in guinea-pig cultured tracheal smooth muscle. Br J Pharmacol 110: 477-481.
23. REGOLI D, BARABE J, 1980. Pharmacology of bradykinin and related kinins. Pharmacol Rev 32: 1-46.
24. REGOLI D, JUKIC D, GOBEIL F RHALEB N-E, 1993. Receptors for bradykinin and related kinins: a critical analysis. Can J Physiol Pharmacol 71: 556-567.
25. RUBIN LE, LEVI R, 1995. Protective role of bradykinin in cardiac anaphylaxis. Coronary-vasodilating and anti-arrhythmic activities mediated by autocrine/paracine mechanisms. Circ Res 76: 434-440.
26. 3H)noradrenaline release from rat brain cortex slices. J Neurochem 46: 1711-1717.
27. SCHÖMIG A, FISCHER S, KURZ T, RICHARDT G, SCHÖMIG E, 1987. Nonexocytotic release of endogenous nor-adrenaline in the ischemic and anoxic rat heart. Mechanism and metabolic requirements. Circ Res 60: 194-205.
28. SCHWARZ P, DIEM R, DUN NJ, FÖRSTERMANN U, 1995. Endogenous and exogenous nitric oxide inhibits nor-adrenaline release from rat heart sympathetic nerves. Circ Res 77: 841-848.
29. STARKE K, PESKAR BA, SCHUMACHER KA, TAUBE HD, 1977. Bradykinin and postganglionic sympathetic transmission. Naunyn-Schmiedeberg's Arch Pharmacol 299: 23-32.
30. TOKUMOTO H, CROXTALL JD, FLOWER RJ, 1994. Differential role of extra-and intracellular calcium in bradykinin and interleukin 1α stimulation of arachidonic release from A549 cells. Biochim Biophys Acta 1211: 301-309.
31. TOULLEC D, PIANETTI P, COSTE H, BELLEVERGUE P, GRAND-PERRET T, AJAKANE M, BAUDET V BOISSIN P, BOURSIER E, LORIOLLE F, 1991. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266: 15771-15781.
32. 3H-noradrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 323: 128-140.
33. TRENDELENBURG U, SCHÖNFELD CL, SCHÖMIG E, 1990. The efficiency of the neuronal re-uptake of noradrenaline and the inhomogeneity of labelling of an incubated tissue inhomogeneity. Neurochem Int 17: 139-147.
34. WEISS C, ATLAS D, 1991. The bradykinin receptor - a putative receptor-operated channel in PC 12 cells: studies of neurotransmitter release and inositol phosphate accumulation. Brain Res 543: 102-110.
35. 2+ mobilization by arachidonic acid. J Biol Chem 261: 3501-3511.
36. ZANZINGER J, ZHENG X, BASSENGE E, 1984. Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism. Cardiovasc Res 28: 209-214.